Kevin Kaijun Li
Vorsitzender bei Neurelis, Inc.
Ursprung des Netzwerks ersten Grades von Kevin Kaijun Li
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Wugen, Inc.
 Wugen, Inc. Packaged SoftwareTechnology Services Wugen, Inc. develops CAR-T therapy platform for cancer therapies. The company was founded by Matthew Cooper and John F. DiPersio and is headquartered in St. Louis, MO.
11
| Holding Company | Packaged Software | 11 |
Neurelis, Inc.
 Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA.
10
| Holding Company | Pharmaceuticals: Major | 10 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Kevin Kaijun Li
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Sales & Marketing | |
| GT BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
| QUESTCOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Operating Officer Sales & Marketing | |
JPMorgan Securities LLC
 JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Investment Banks/Brokers | Analyst-Equity | |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
Vascular Pathways, Inc.
 Vascular Pathways, Inc. Medical SpecialtiesHealth Technology Vascular Pathways, Inc. develops and commercializes vascular access devices. Its product, AccuCath Intravenous Catheter is a peripheral catheter technology designed to provide acces to veins. It has an AccuTip nitinol guidewire that creates a pathway within the vessel and deploys the catheter atraumatically. The company was founded by Amir Belson in 2005 and is headquartered in Franklin Lakes, NJ. | Medical Specialties | Director/Board Member | |
| ZOGENIX, INC. | Pharmaceuticals: Major | Founder Sales & Marketing | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| EVOLUS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| TURG POIN | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| HELIUS MEDICAL TECHNOLOGIES, INC. | Medical Specialties | Director/Board Member | |
| DERMATA THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Abingworth LLP
 Abingworth LLP Investment ManagersFinance Abingworth LLP (Abingworth) is a venture capital firm founded in the year 1973 Peter Dickson and Anthony Montagu. The firm headquartered in London and additional offices in San Francisco and Boston. Abingworth LLP became part of The Carlyle Group Inc. (NASDAQ: CG) on 3rd August 2022. | Investment Managers | Chief Investment Officer Private Equity Investor | |
| University of Oxford | College/University | Corporate Officer/Principal Doctorate Degree | |
MVM Partners LLP
 MVM Partners LLP Investment ManagersFinance MVM Partners LLP (MVM Partners) is a venture capital firm founded in 1997. The firm is headquartered in London, the United Kingdom. | Investment Managers | Private Equity Investor Private Equity Investor | |
| University of Cambridge | College/University | Doctorate Degree Undergraduate Degree | |
| The Johns Hopkins University | College/University | Graduate Degree | |
| University of Arizona | College/University | Undergraduate Degree | |
| NAVAMEDIC ASA | Medical Distributors | Director/Board Member | |
Intermediate Capital Group Plc (Private Equity)
 Intermediate Capital Group Plc (Private Equity) Investment ManagersFinance Intermediate Capital Group Plc (Private Equity) (ICG) is a private equity division of Intermediate Capital Group Plc founded in 1989. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
| DESTINY PHARMA PLC | Pharmaceuticals: Major | Director/Board Member | |
| BICYCLE THERAPEUTICS PLC | Biotechnology | Director/Board Member | |
Exicure Operating Co.
 Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| IO BIOTECH, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| EXICURE, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Sailing Capital Advisors Hong Kong Ltd
 Sailing Capital Advisors Hong Kong Ltd Investment ManagersFinance Sailing Capital Advisors Hong Kong Ltd (Sailing Capital Advisors) is a private equity subsidiary of Sailing Capital Management Co Ltd founded in 2012. The firm is headquartered in Wan Chain, Hong Kong. | Investment Managers | Director/Board Member | |
| PIERIS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Bridge Valley Ventures LLP
 Bridge Valley Ventures LLP Investment ManagersFinance Bridge Valley Ventures LLP is a Venture Capital firm founded in 2017. Bridge Valley Ventures LLP is headquartered in Cambridge. | Investment Managers | Private Equity Investor | |
Itolerance, Inc.
 Itolerance, Inc. BiotechnologyHealth Technology Itolerance, Inc. is an American biotechnology company that specializes in developing regenerative medicines. The private company was founded by Cameron Gray and is currently led by CEO Anthony J. Japour. | Biotechnology | Director/Board Member | |
Cereius, Inc.
 Cereius, Inc. BiotechnologyHealth Technology Cereius, Inc. develops novel radio-labeled therapeutics for treating solid tumor brain metastasis. The firm delivers new targeted classes of both radiologic diagnostics and radiotherapeutics for the treatment of cancers in the brain. The company was founded by Kimberly Blackwell and Michael R. Zalutsky in 2017 and is headquartered in Durham, NC. | Biotechnology | Chief Executive Officer | |
| LAVA THERAPEUTICS N.V. | Biotechnology | Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
| CELLULAR BIOMEDICINE GROUP, INC. | Biotechnology | Director/Board Member | |
Sailing Capital Management Co. Ltd.
 Sailing Capital Management Co. Ltd. Investment ManagersFinance Shanghai Sailing Capital Management Co. Ltd. (Sailing Capital) is a private equity firm founded in 2011. The firm is headquartered in Shanghai. | Investment Managers | Director/Board Member | |
AEON Biopharma Sub, Inc.
 AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | Pharmaceuticals: Other | Director/Board Member | |
| ACTICOR BIOTECH SAS | Biotechnology | Director/Board Member | |
| UCL Medical School | College/University | Doctorate Degree | |
| Hunan University of Chinese Medicine | College/University | Graduate Degree | |
| BIODEXA PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director/Board Member | |
Blueberry Therapeutics Ltd.
 Blueberry Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Blueberry Therapeutics Ltd. engages in the development of innovative medicines. It offers nanomedicine, anti infection and anti microbial, anti inflammatory bowel diseases, acne, dermatitis and wound medicines. The company was founded by John Ridden and Mike Davies and is headquartered in Macclesfield, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 27 |
| Vereinigtes Königreich | 12 |
| Hong Kong | 3 |
| Norwegen | 2 |
| Japan | 2 |
Sektoral
| Health Technology | 27 |
| Finance | 9 |
| Consumer Services | 8 |
| Commercial Services | 4 |
| Distribution Services | 2 |
Operativ
| Director/Board Member | 135 |
| Corporate Officer/Principal | 52 |
| Chairman | 37 |
| Independent Dir/Board Member | 35 |
| Founder | 23 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| David Hale | 54 |
| John McKearn | 25 |
| Peter Kiener | 25 |
| Bosun Hau | 23 |
| Mark Alles | 20 |
| Bali Muralidhar | 20 |
| Huai Zheng Peng | 19 |
| David Smith | 17 |
| Steve Cartt | 10 |
| Craig Charles Chambliss | 10 |
| Priyanka Belawat | 10 |
| Natalie Mount | 10 |
| Brittany Bradrick | 9 |
| Enrique Carrazana | 9 |
| Stephen H. Jenner | 8 |
- Börse
- Insiders
- Kevin Kaijun Li
- Unternehmensverbindungen
